1. 561 DuoBody®-PD-L1×4–1BB (GEN1046) induces superior immune-cell activation, cytokine production and cytotoxicity by combining PD-L1 blockade with conditional 4–1BB co-stimulation. (10th December 2020) Authors: Muik, Alexander; Altintas, Isil; Kosoff, Rachelle; Gieseke, Friederike; Schödel, Kristina; Salcedo, Theodora; Burm, Saskia; Toker, Aras; Kranz, Lena; Vormehr, Mathias; Eisel, David; Fereshteh, Mark; Türeci, Özlem; Breij, Esther; Ahmadi, Tahamtan; Sahin, Ugur; Jure-Kunkel, Maria Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A338 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 561 DuoBody®-PD-L1×4–1BB (GEN1046) induces superior immune-cell activation, cytokine production and cytotoxicity by combining PD-L1 blockade with conditional 4–1BB co-stimulation. (9th November 2020) Authors: Muik, Alexander; Altintas, Isil; Kosoff, Rachelle; Gieseke, Friederike; Schödel, Kristina; Salcedo, Theodora; Burm, Saskia; Toker, Aras; Kranz, Lena; Vormehr, Mathias; Eisel, David; Fereshteh, Mark; Türeci, Özlem; Breij, Esther; Ahmadi, Tahamtan; Sahin, Ugur; Jure-Kunkel, Maria Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A595 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. An Fc-inert PD-L1×4-1BB bispecific antibody mediates potent anti-tumor immunity in mice by combining checkpoint inhibition and conditional 4-1BB co-stimulation. (31st December 2022) Authors: Muik, Alexander; Altintas, Isil; Gieseke, Friederike; Schoedel, Kristina B; Burm, Saskia M; Toker, Aras; Salcedo, Theodora W.; Verzijl, Dennis; Eisel, David; Grunwitz, Christian; Kranz, Lena M; Vormehr, Mathias; Satijn, David P.E.; Diken, Mustafa; Kreiter, Sebastian; Sasser, Kate; Ahmadi, Tahamta... Journal: Oncoimmunology Issue: Volume 11:Number 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activity. Issue 6 (10th June 2022) Authors: Muik, Alexander; Adams III, Homer C; Gieseke, Friederike; Altintas, Isil; Schoedel, Kristina B; Blum, Jordan M; Sänger, Bianca; Burm, Saskia M; Stanganello, Eliana; Verzijl, Dennis; Spires, Vanessa M; Vascotto, Fulvia; Toker, Aras; Quinkhardt, Juliane; Fereshteh, Mark; Diken, Mustafa; Satijn, Dav... Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 6(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗